PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2024CHEST JournalOpen Access

Antithrombotic Therapy for VTE Disease

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Guidance statements from the most recent full CHEST VTE guidelines and two subsequent updates had not been gathered into a single source.

Design

Evidence-based guideline update using a modified Delphi process and GRADE methodology

Key result

A unified collection of 58 currently relevant guidance statements for antithrombotic therapy in VTE disease was assembled from the 2012 CHEST guidelines and subsequent updates.

Authors

SSScott M. StevensSWScott C. WollerLKLisa Baumann Kreuziger

Discussion

Loading...

Member takes

Overview

Offers clinicians a unified reference of 58 current VTE antithrombotic recommendations; extends prior guidelines by retiring 5 obsolete statements.

Structured PICO

P
Population
Patients with Venous Thromboembolism (VTE) disease
I
Intervention
Antithrombotic therapy

This document serves as a unified collection of currently relevant guidance statements from the preceding three CHEST guidelines on antithrombotic therapy for VTE disease.

Cite This Study

Stevens et al. (2024) conducted a review in Venous Thromboembolism (VTE) Disease. Antithrombotic Therapy was evaluated on Guidance statements relevant to current clinical care. A unified collection of 58 currently relevant guidance statements for antithrombotic therapy in VTE disease was assembled from the 2012 CHEST guidelines and subsequent updates.

synapsesocial.com/papers/6aa115569318be7e6b997f27https://doi.org/10.1016/j.chest.2024.03.003
View Full Paper
Ask AI
Bookmark
Share